MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
BRNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Barinthus Biotherapeutics (BRNS) Ownership - Who owns Barinthus Biotherapeutics?

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
20400 Century Boulevard
Phone
+1 443 917-0966
Employees
14
Web
https://www.barinthusbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
30.23M
P/E Ratio
16.64
Total Cash
59.3M
Projected Growth
N/A
Total Debt
10.3M
Revenue
N/A
Risk (Beta)
-1.39
Dividend Yield
N/A
Total Cash/Share
1.45
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
BRNS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for BRNS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
20400 Century Boulevard
Phone
+1 443 917-0966
Employees
14
Web
https://www.barinthusbio.com